The Future for UK Pharmaceuticals R&D – Innovation through Partnership

From 2011-05-12 to 2011-04-12

Pharmaceutical R&D is in a period of significant transition at present. Following a period of extensive restructuring, mergers and acquisitions, big pharma does not have the pre-eminence it once did over the marketplace. Whilst the UK has a strong track record, particularly in R&D, the increasing stratification of the marketplace, spiralling costs of developing new drugs and greater global competition have required the industry as a whole to continually look at new ways of working.

This timely briefing will examine the future for the UK pharmaceuticals sector. By drawing upon best practice from around the country and bringing in some of the key decision makers, the day will look at how industry, SMEs and academia can work in partnership to create innovative products that will keep the UK at the cutting edge of global R&D

Url:	http://www.inside-pharma.co.uk/courses.php